| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | J J Deeks | |
| J D Goldberg | |||
| V A Feldstein | |||
| W Hosmer | |||
| R Smith-Bindman | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Down syndrome | Q47715 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 1044-1055 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis | |
| P478 | volume | 285 |
| Q40537208 | A novel mutation in the renal V2 receptor gene in a boy with trisomy 21. |
| Q79271211 | AIUM Practice Guideline for the Performance of an Antepartum Obstetric Ultrasound Examination |
| Q44138046 | AIUM practice guideline for the performance of obstetric ultrasound examinations |
| Q51546625 | Adjusted risk for trisomy 21 after the anomaly scan. How accurate is the Fetal Medicine Foundation algorithm? |
| Q34140689 | Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing |
| Q24801905 | An ethnic predilection for fetal echogenic intracardiac focus identified during targeted midtrimester ultrasound examination: A retrospective review |
| Q51998998 | An isolated echogenic heart focus is not an indication for amniocentesis in 12,672 unselected patients. |
| Q24241578 | Antenatal screening for Down's syndrome |
| Q24236033 | Antenatal screening for Down's syndrome: generic protocol |
| Q79298661 | Combined Sonographic and Biochemical Markers for Down Syndrome Screening |
| Q35864215 | Comparison of Fetal Nuchal Fold Thickness Measurements by Two- and Three-Dimensional Ultrasonography (3DXI Multislice View). |
| Q46824060 | Comparison of single versus multiple echogenic foci in the fetal heart regarding risk of aneuploidy |
| Q51501850 | Contribution of "modified genetic sonography" to the combined test as a screening method for chromosomal abnormalities. |
| Q35736144 | Controversial ultrasound findings |
| Q34191091 | Down's syndrome |
| Q40537875 | Echogenic intracardiac focus on second trimester ultrasound: prevalence and significance in a Middle Eastern population |
| Q46359286 | Echogenic intracardiac focus: potential for misdiagnosis |
| Q58666037 | Ethical dimensions of nuchal translucency screening |
| Q46968907 | Ethnic variation in the prevalence of echogenic intracardiac foci and the association with Down syndrome |
| Q42860877 | Evidence of bias and variation in diagnostic accuracy studies |
| Q44357597 | Fetal nuchal fold thickness measurement between 18 and 24 weeks of pregnancy: reference intervals for a Brazilian population |
| Q48056782 | Fetal ultrasound examination and assessment of genetic soft markers in Sweden: are ethical principles respected? |
| Q36308492 | First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. |
| Q24187589 | First trimester serum tests for Down's syndrome screening |
| Q36308489 | First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening |
| Q58029043 | Isolated absent or hypoplastic nasal bone in the second trimester fetus: is amniocentesis necessary? |
| Q47740636 | Isolated intracardiac echogenic focus on routine ultrasound: implications for practice |
| Q53390671 | Landmarks in genetics through philately: Down syndrome. |
| Q36884167 | Management options for echogenic intracardiac focus and choroid plexus cysts: a review including Australian Association of Obstetrical and Gynaecological Ultrasonologists consensus statement |
| Q34315322 | Meta-analysis of second-trimester markers for trisomy 21. |
| Q40859927 | Methods for the joint meta-analysis of multiple tests |
| Q43988886 | Model-predicted performance of second-trimester Down syndrome screening with sonographic prenasal thickness |
| Q51808907 | New contingent sequential screening model for Down syndrome based on the combined test associated with modified genetic sonography. |
| Q36335133 | Non-Invasive Screening Tools for Down's Syndrome: A Review |
| Q44549808 | Normal ranges for fetal nasal bone length determined by ultrasound at 18-20 weeks of gestation in a multiethnic Australian population |
| Q53199970 | Novel chemiluminescent imaging microtiter plates for high-throughput detection of multiple serum biomarkers related to Down's syndrome via soybean peroxidase as label enzyme. |
| Q34940389 | Pattern of secretion of pregnancy-associated plasma protein-A (PAPP-A) during pregnancies complicated by fetal aneuploidy, in vivo and in vitro |
| Q35843634 | Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women. |
| Q35988618 | Prenatal detection of an interstitial deletion in 4p15 in a fetus with an increased nuchal skin fold measurement |
| Q60054137 | Prenatal diagnosis and pregnancy outcome analysis of thickened nuchal fold in the second trimester |
| Q35192037 | Prenatal diagnosis for detection of aneuploidy: the options |
| Q51871113 | Prenatal diagnosis of chromosomal abnormalities in a resource-poor setting. |
| Q30484759 | Prenatal imaging: ultrasonography and magnetic resonance imaging |
| Q48889120 | Prenatal screening and the assessment of risk: the view from the other side |
| Q36754874 | Prenatal screening for fetal aneuploidy |
| Q33958921 | Prenatal screening for fetal aneuploidy in singleton pregnancies |
| Q36783335 | Prenatal screening methods for aneuploidies |
| Q37606822 | Prenatal sonographic features of fetuses in trisomy 13 pregnancies (I). |
| Q84836506 | Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA |
| Q33891290 | Prenatal ultrasound screening for external ear abnormality in the fetuses |
| Q35204606 | Reasons for trisomy 13 or 18 births despite the availability of prenatal diagnosis and pregnancy termination |
| Q73294195 | Relationship of isolated fetal intracardiac echogenic focus to trisomy 21 at the mid‐trimester sonogram in women younger than 35 years |
| Q36856774 | Revised guidelines on management of antenatal hydronephrosis |
| Q45163351 | Revised guidelines on management of antenatal hydronephrosis |
| Q51376807 | Role of fetal echocardiography in stepwise sequential screening for chromosomal disorders (combined test associated with modified genetic sonography). |
| Q36776424 | Role of second-trimester genetic sonography after Down syndrome screening |
| Q38179321 | Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing |
| Q44592486 | Screening advances and diagnostic choice: the problem of residual risk |
| Q22252964 | Second trimester serum tests for Down's Syndrome screening |
| Q96765781 | Segmental aneuploidies in fetuses with isolated echogenic intracardiac focus among women younger than 35 years |
| Q48160076 | Swedish University Students' Opinion Regarding Information About Soft Markers |
| Q38178203 | Systematic review of the clinical prediction rules for the calculation of the risk of Down syndrome based on ultrasound findings in the second trimester of pregnancy. |
| Q35574447 | The Genetic Sonogram in Second Trimester Down Syndrome Screening |
| Q51697729 | The effect of graphical and numerical presentation of hypothetical prenatal diagnosis results on risk perception. |
| Q30447783 | The effect of maternal vitamin D concentration on fetal bone. |
| Q52030959 | The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. |
| Q37764348 | The performance of second trimester long bone ratios for Down syndrome screening is influenced by gestational age. |
| Q38917458 | The recurrence of sonographic 'soft markers': ominous sign or 'just' genetics? |
| Q27016097 | The role of ultrasound in the diagnosis of fetal genetic syndromes |
| Q34839043 | The significance of the nuchal fold in the second trimester fetus |
| Q37119113 | Time to reconsider our approach to echogenic intracardiac focus and choroid plexus cysts |
| Q50732804 | Ultrasonographic fetal soft markers in a low-risk population: prevalence, association with trisomies and invasive tests. |
| Q36568408 | Ultrasonographic soft markers of aneuploidy in second trimester: are we lost? |
| Q30917622 | Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas |
| Q47853412 | Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation. |
| Q24186912 | Urine tests for Down's syndrome screening |
| Q46557309 | Variation of fetal humeral length in second-trimester fetuses according to race and ethnicity |
| Q47340400 | Women's experiences of unexpected ultrasound findings |
| Q80186296 | [Autopsy findings related to Down's syndrome: 101 cases] |
| Q80361819 | [Role of "subtle" ultrasonographic signs during antenatal screening for trisomy 21 during the second trimester of pregnancy: meta-analysis and CPDPN protocol of the Grenoble University Hospital] |
Search more.